Cancer immunotherapy: a future paradigm shift in the treatment of non–small cell lung cancer
VK Anagnostou, JR Brahmer - Clinical Cancer Research, 2015 - AACR
… non–small cell lung cancer (NSCLC) treatment focusing on vaccine approaches to elicit
specific immune responses and development of inhibitors of the molecular mediators of cancer-…
specific immune responses and development of inhibitors of the molecular mediators of cancer-…
[HTML][HTML] Therapeutic management options for stage III non-small cell lung cancer
SM Yoon, T Shaikh, M Hallman - World journal of clinical oncology, 2017 - ncbi.nlm.nih.gov
… Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (… population, making management for these …
lung cancers are non-small cell lung cancer (… population, making management for these …
Prognostic factors in non-small cell lung cancer: a decade of progress
MD Brundage, D Davies, WJ Mackillop - Chest, 2002 - Elsevier
… and tumor factors that are predictive of survival for patients with non-small cell lung cancer
(… factors relevant to patients with lung cancer receiving radiation therapy with curative intent. …
(… factors relevant to patients with lung cancer receiving radiation therapy with curative intent. …
Advances in chemotherapy of non-small cell lung cancer
JR Molina, AA Adjei, JR Jett - Chest, 2006 - Elsevier
… part of the treatment of lung cancer has expanded significantly, … For advanced stage non-small
cell lung cancer (NSCLC), … are now the standard of care in patients with advanced stage …
cell lung cancer (NSCLC), … are now the standard of care in patients with advanced stage …
Tracking the evolution of non–small-cell lung cancer
M Jamal-Hanjani, GA Wilson… - … England Journal of …, 2017 - Mass Medical Soc
Background Among patients with non–small-cell lung cancer (NSCLC), data on intratumor
heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. …
heterogeneity and cancer genome evolution have been limited to small retrospective cohorts. …
Non-small-cell lung cancers: a heterogeneous set of diseases
Z Chen, CM Fillmore, PS Hammerman, CF Kim… - … Reviews Cancer, 2014 - nature.com
… underlie lung cancer development and possible treatments in the past decade present the
opportunity to integrate information from multiple approaches for future lung cancer treatment. …
opportunity to integrate information from multiple approaches for future lung cancer treatment. …
Update of incidence, prevalence, survival, and initial treatment in patients with non–small cell lung cancer in the US
… A review of the management of elderly patients with non-small-cell lung cancer. … A
review of the management of elderly patients with non-small-cell lung …
review of the management of elderly patients with non-small-cell lung …
Impact of age and comorbidity on non–small-cell lung cancer treatment in older veterans
S Wang, ML Wong, N Hamilton, JB Davoren… - … of Clinical Oncology, 2012 - ascopubs.org
… -recommended treatment was assessed for 20,511 veterans age ≥ 65 years with non–small-cell
lung cancer (NSCLC) in the Veterans Affairs (VA) Central Cancer Registry from 2003 to …
lung cancer (NSCLC) in the Veterans Affairs (VA) Central Cancer Registry from 2003 to …
Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
Non-small Cell Lung Cancer Collaborative Group - Bmj, 1995 - bmj.com
… At the outset of this meta- analysis there wasconsiderable pessimism about the treatment
of non-small cell lung cancer. Although the observed effects are modest, these results offer …
of non-small cell lung cancer. Although the observed effects are modest, these results offer …
[HTML][HTML] SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
M Majem, O Juan, A Insa, N Reguart, JM Trigo… - … Translational Oncology, 2019 - Springer
… The pathological diagnosis of non-small cell lung cancer (NSCLC) … Lung Cancer (IASLC)
provided adenocarcinoma classification as well as key recommendations for the management …
provided adenocarcinoma classification as well as key recommendations for the management …